BEAT - NASDAQ

HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026
-13.99M
Operating Cash Flow
-3%
3Y+41.0%
5Y+2231.0%
10Y-136.0%
-600.00K
Investing Cash Flow
199%
3Y-
5Y-
10Y-98.0%
16.59M
Financing Cash Flow
1816%
3Y+4640.0%
5Y+2580.0%
10Y+1063.0%
BEAT

HeartBeam, Inc. Cash Conversion Engine

BEAT · NASDAQ
Net Income-21.02M
Depreciation & Amortization40.00K
Stock-Based Compensation5.15M
Change in Working Capital0.00
Others1.84M
Capital Expenditures-600.00K
Free Cash Flow-14.59M

Cash Flow Quality Analysis

FCF Conversion Rate

69.4%

Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.

CapEx Intensity

-4.3%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+0.6%

Flat FCF growth. Stable but not expanding—monitor for signs of business maturity or temporary headwinds.

Working Capital Impact

+$0.00

Neutral working capital impact. Changes in current assets and liabilities balanced out.

HeartBeam, Inc. Cash Flow Statement

BEAT • NASDAQ

HeartBeam, Inc. Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007Dec 2006
OPERATING ACTIVITIES
Net Income
-21M
-19.4M
-14.6M
-13M
-4.4M
-1.1M
-536K
42.8M
-16M
53.4M
7.4M
-9.8M
-7.3M
-12.2M
-61.4M
-19.9M
-20.5M
9.2M
-358.1K
-7.6M
Depreciation & Amortization
40K
7K
0.0
0.0
0.0
0.0
0.0
40.2M
28.6M
14.3M
12.5M
12.6M
12.3M
9.4M
12.1M
12.1M
10.9M
8.7M
4.5M
2.7M
Change in Deferred Taxes
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-2.3M
6.1M
-38.1M
245K
-2.5M
53K
-1M
0.0
0.0
0.0
0.0
0.0
0.0
Stock-Based Compensation
5.1M
4.3M
3.2M
1.1M
192K
10K
0.0
0.0
7.7M
6.5M
5M
4M
3.3M
3.7M
4M
3.9M
16.6M
3.4M
0.0
0.0
Other Non-Cash Items
1.8M
0.0
0.0
0.0
2.1M
276K
242K
-75.1M
-13.7M
-2.1M
-19.8M
15.6M
2.6M
38.1M
53.8M
29M
9.4M
-65.6M
-52.5M
5M
Change in Working Capital
0.0
671K
-662K
1.9M
-1.1M
182K
76K
57.9M
11.1M
4.9M
9M
-11.1M
283K
-32.2M
-3.5M
-14.7M
-8.6M
54.6M
48.1M
-2.9M
Cash from Operating Activities
-14M
-14.5M
-12.1M
-9.9M
-3.2M
-600K
-218K
72.7M
23.8M
38.9M
14.4M
8.8M
11.3M
5.7M
5M
10.4M
7.9M
10.3M
-237.6K
-2.9M
INVESTING ACTIVITIES
Investments in Property, Plant, and Equipment
-600K
-201K
-256K
(0.0)
(0.0)
(0.0)
(0.0)
-24.6M
-13.7M
-10.9M
-13.6M
-12.8M
-8.2M
-6M
-4M
-5.2M
-19.9M
-11.8M
-13.1M
-913.7K
Purchase of Investments
(3.8M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-1.3M
(0.0)
(0.0)
(0.0)
(0.0)
-11.9M
-49.7M
-36.9M
(0.0)
(0.0)
(0.0)
(0.0)
Sale/Maturity of Investments
-3.8M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
39.6M
47.9M
9.8M
0.0
0.0
0.0
0.0
Other Investing Items
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-4.2M
-162.2M
-25.3M
0.0
-14.1M
0.0
-28.2M
0.0
-9.9M
0.0
-4.8M
-45.9M
0.0
Cash from Investing Activities
-600K
-201K
-256K
(0.0)
(0.0)
(0.0)
(0.0)
-28.9M
-177.2M
-36.2M
-13.6M
-26.9M
-8.2M
-6.4M
-5.7M
-42.3M
-19.9M
-16.6M
-59M
-913.7K
FINANCING ACTIVITIES
Net Issuance of Common Stock
0.0
730K
25M
348K
14.7M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net Issuance of Debt
0.0
0.0
0.0
0.0
1.7M
619K
66K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Share Repurchases
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-180.0
Other Financing Items
16.6M
136K
0.0
2K
0.0
0.0
140K
601K
166.5M
1.4M
-1.8M
15.9M
763K
440K
509K
1.5M
3M
46.4M
73.4M
5M
Cash from Financing Activities
16.6M
866K
25M
350K
16.4M
619K
206K
601K
166.5M
1.4M
-1.8M
15.9M
763K
440K
509K
1.5M
3M
46.4M
73.4M
5M
CASH FLOW SUMMARY
Effect of Foreign Exchange Rates
0.0
0.0
0.0
0.0
0.0
0.0
0.0
371K
-81K
-31K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net Change in Cash
2M
-13.8M
12.6M
-9.6M
13.2M
19K
-12K
44.9M
13M
4.1M
-1M
-2.1M
3.9M
-233K
-174K
-30.4M
-9M
40.1M
14.2M
1.2M
Cash at Beginning of Period
2.4M
16.2M
3.6M
13.2M
24K
5K
17K
36M
23.1M
19M
20M
22.2M
18.3M
18.5M
18.7M
49.2M
58.2M
18.1M
3.9M
2.8M
Cash at End of Period
4.4M
2.4M
16.2M
3.6M
13.2M
24K
5K
80.9M
36M
23.1M
19M
20M
22.2M
18.3M
18.5M
18.7M
49.2M
58.2M
18.1M
3.9M
Free Cash Flow
-14.6M
-14.7M
-12.3M
-9.9M
-3.2M
-600K
-218K
48.1M
10.1M
28M
750K
-4M
3.1M
-219K
1.1M
5.1M
-12M
-1.5M
-13.3M
-3.8M

SEC Filings

BEAT - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-K

10-K 2025 FY

FY

March 12, 2026
December 31, 2025
2025
View Filing
S-3

S-3

N/A

February 09, 2026
February 09, 2026
 
View Filing
8-K

8-K 2025

N/A

November 21, 2025
November 20, 2025
2025
View Filing
10-Q

10-Q 2025 Q3

Q3

November 13, 2025
September 30, 2025
2025
View Filing
10-Q

10-Q 2025 Q2

Q2

August 13, 2025
June 30, 2025
2025
View Filing
8-K

8-K 2025

N/A

July 16, 2025
July 11, 2025
2025
View Filing
DEF 14A

DEF 14A 2024

N/A

May 29, 2025
December 31, 2024
2024
View Filing
10-Q

10-Q 2025 Q1

Q1

May 13, 2025
March 31, 2025
2025
View Filing
8-K

8-K 2025

N/A

May 05, 2025
May 05, 2025
2025
View Filing
8-K

8-K 2025

N/A

April 25, 2025
April 21, 2025
2025
View Filing
Showing 1 to 10 of 69 filings

Related Guides

Blog Categories

Continue your BEAT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.